Table 4.
The doubling time (Dt) of yeasts and the inhibition rate under 80 mM AA or 80 mM AA co-treated with SIP or FL or WCPP administration at concentrations of 0.125, 0.25, 0.5, 1 and 2 mg/mL.
| Groups | Vehicle | 80 mM AA | Combination | |||||
|---|---|---|---|---|---|---|---|---|
| Concentration of Polysaccharide (mg/mL) | ||||||||
| 0.125 | 0.25 | 0.5 | 1 | 2 | ||||
| SIP + 80 mM AA | 6.60 ± 0.05 * | 6.75 ± 0.01 * | 6.84 ± 0.13 * | 7.30 ± 0.05 * | 7.82 ± 0.02 | |||
| Dt (h) | 5.23 ± 0.02 * | 7.73 ± 0.04 | FL + 80 mM AA | 7.63 ± 0.20 | 7.23 ± 0.18 * | 7.16 ± 0.15 * | 7.41 ± 0.08 * | 7.54 ± 0.07 * |
| WCPP + 80 mM AA | 7.07 ± 0.19 * | 7.09 ± 0.09 * | 7.23 ± 0.07 * | 7.63 ± 0.03 * | 7.87 ± 0.06 * | |||
| SIP + 80 mM AA | 29.69 ± 0.32 * | 31.31 ± 0.46 * | 31.91 ± 0.01 * | 35.84 ± 0.98 * | 40.35 ± 0.17 | |||
| Inhibition rate (%) | 0 * | 39.76 ± 0.50 | FL + 80 mM AA | 38.04 ± 1.15 | 34.69 ± 1.41 * | 34.10 ± 1.12 * | 36.13 ± 0.67 * | 37.04 ± 0.35 * |
| WCPP + 80 mM AA | 34.96 ± 1.07 * | 34.16 ± 0.86 * | 34.41 ± 0.01 * | 37.31 ± 0.34 * | 39.96 ± 0.25 | |||
* Indicated p < 0.05 vs. 80 mM AA group.